The first stop for professional medicines advice

Articles

694 results

Combined hormonal contraceptive vaginal ring

4 October 2021SPS PGD template for the supply of combined hormonal vaginal ring for contraception.

Ulipristal acetate 30mg tablets for emergency contraception

4 October 2021SPS PGD template for the supply and/or administration of ulipristal acetate 30mg tablet for emergency contraception.

Levonorgestrel 1500 microgram tablets for emergency contraception

4 October 2021SPS PGD template for the supply and/or administration of levonorgestrel 1500 microgram tablets for emergency contraception.

About the SPS Medicines Governance Do Once Programme

4 October 2021The programme reduces duplication of effort and improves quality and consistency through national PGD templates and Medicines Policy and Governance principles

Implementing the SPS Patient Group Direction, Written Instruction and protocol templates

4 October 2021SPS national templates can be implemented by organisations to improve consistency and reduce duplication of effort.

Etonogestrel (e.g. Nexplanon®) implant for contraception

4 October 2021SPS PGD template for the insertion of etonogestrel (e.g. Nexplanon®) 68mg subdermal implant for contraception.

Lidocaine injection for subdermal etonogestrel in contraception

4 October 2021SPS PGD template for administering lidocaine injection to facilitate insertion and/or removal of subdermal etonogestrel (e.g. Nexplanon®) implants.

Product Design Considerations for Optimising ATMP Implementation in the NHS

20 August 2021This guidance provides advice for ATMP developers, highlighting implementation challenges faced by the NHS and suggesting design consideration to minimise them.

A Guide to Quality Control Chemical Testing of Aseptically Prepared Products

2 July 2021This document covers laboratory chemical analysis of aseptically prepared products. The reasons for analysis are outlined in Section 2 of this document

Off label medicine use under a Patient Group Direction

10 June 2021This article explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off-label').